Skip to main content
SpringerLink
Log in
Book cover

Viral Diseases in Pregnancy pp 128–155Cite as

Human Immunodeficiency Virus

  • Chapter

  • 112 Accesses

Part of the book series: Clinical Perspectives in Obstetrics and Gynecology ((CPOG))

Abstract

Infection with human immunodeficiency virus type 1 (HIV-1) produces a chronic progressive illness resulting in the acquired immunodeficiency syndrome (AIDS) and, ultimately, death. Although AIDS was first described in gay and bisexual men in 1981, cases were also reported in US women.1 The increasing prevalence of HIV-1 and AIDS among reproductive-age women was first recognized in 19872 and has continued to in-crease, affecting predominately black and Hispanic, inner city women.3 By 1989, HIV/ AIDS became the sixth leading cause of death nationwide among women 25 to 44 years of age.4 The number of AIDS cases reported to the Centers for Disease Control and Prevention continues to increase exponentially, with almost 12,000 women (44% of the cumulative total of AIDS cases reported in women) reported in 1991 and 1992.5

The opinions expressed in this article are those of the author and do not represent the official position of the U.S. Public Health Service

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Centers for Disease Control. Follow-up on Kaposi’s sarcoma and Pneumocystis pneumonia. Morb Mortal Wkly Rep. 1981; 30: 409–410.

    Google Scholar 

  2. Guinan ME, Hardy A. Epidemiology of AIDS in women in the United States. JAMA. 1987; 257: 2039–2042.

    Google Scholar 

  3. Ellerbrock TV, Bush TJ, Chamberland ME, et al. Epidemiology of women with AIDS in the United States, 1981 through 1990: A comparison with heterosexual men with AIDS. JAMA. 1991; 265: 2971–2975.

    PubMed  CAS  Google Scholar 

  4. Centers for Disease Control. Mortality patterns—United States, 1989. Morb Mortal Wkly Rep. 1992; 41: 121–125.

    Google Scholar 

  5. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. February 1993:1–23.

    Google Scholar 

  6. Centers for Disease Control. The second 100 000 cases of acquired immunodeficiency syndrome. Morb Mortal Wkly Rep. 1992; 41: 28–29.

    Google Scholar 

  7. Centers for Disease Control. Unexplained immunodeficiency and opportunistic infections in infants: New York, New Jersey and California. Morb Mortal Wkly Rep. 1982; 31: 665–667.

    Google Scholar 

  8. Rubinstein A, Sicklick M, Gupta A, et al. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA. 1983; 249: 2350–2356.

    PubMed  CAS  Google Scholar 

  9. Scott GB, Buck BE, Letterman JG, et al. Acquired immune deficiency syndrome in infants. N Engl J Med. 1984; 310: 76–81.

    PubMed  CAS  Google Scholar 

  10. Oxtoby MJ. Perinatally acquired human immunodeficiency virus infection. Pediatr Infect Dis J. 1990; 9: 609–619.

    PubMed  CAS  Google Scholar 

  11. Gwinn M, Pappaionaou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States—Surveillance using newborn blood samples. JAMA. 1991; 265: 1704–1708.

    PubMed  CAS  Google Scholar 

  12. Michaels D, Levine C. Estimates of the number of motherless youth orphaned by AIDS in the United States. JAMA. 1992; 268: 3456–3461.

    PubMed  CAS  Google Scholar 

  13. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983; 220: 868–871.

    PubMed  CAS  Google Scholar 

  14. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984; 224: 500–503.

    PubMed  CAS  Google Scholar 

  15. Haseltine WA. Molecular biology of the human immunodeficiency virus type 1. FASEB J. 1991; 5: 2349–2360.

    PubMed  CAS  Google Scholar 

  16. Chin J. Current and future dimensions of the HIV/AIDS pandemic in women and children. Lancet. 1990; 336 (l): 221–224.

    PubMed  CAS  Google Scholar 

  17. Global Programme on AIDS. The current global situation of the HIV/AIDS pandemic. Press release, 1992.

    Google Scholar 

  18. Rothenberg R, Woelfel M, Stoneburner R, et al. Survival with the acquired immunodeficiency syndrome: Experience with 5833 cases in New York City. N Engl J Med. 1987; 317: 1297–1302.

    PubMed  CAS  Google Scholar 

  19. Whyte BM, Swanson CE, Cooper DA. Sur-vival of patients with the acquired immunodeficiency syndrome in Australia. Med J Aust. 1989; 150: 358–362.

    PubMed  CAS  Google Scholar 

  20. Friedland GH, Saltzman B, Vileno J, et al. Survival differences in patients with AIDS. AIDS. 1991; 4: 144–153.

    CAS  Google Scholar 

  21. Moore RD, Hidalgo J, Sugland BW, et al. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med. 1991; 324: 1412–1416.

    PubMed  CAS  Google Scholar 

  22. Lemp GF, Payne SF, Neal D, et al. Survival trends for patients with AIDS. JAMA. 1990; 263: 402–406.

    PubMed  CAS  Google Scholar 

  23. Turner BJ, Markson LE, McKee L, et al. Survival patterns of women and men with AIDS: Impact of health care use prior to AIDS (Abstract TuD 112). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  24. Horsburgh RC, Hanson D, Fann SA, et al. Predictors of survival in HIV infection include CD4 + cell count, AIDS-defining condition and therapy but not sex, age, race or risk activity (Abstract MC 3175 ). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  25. Creagh-Kirk T, Doi P, Andrews E, et al. Survival experience among patients with AIDS receiving zidovudine: Follow-up of patients in a compassionate plea program. JAMA. 1988; 260: 3009–3015.

    PubMed  CAS  Google Scholar 

  26. Wiley C, Schrier R, Nelson J, et al. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sei USA. 1986; 83: 7089–7093.

    CAS  Google Scholar 

  27. Cheng-Meyer C, Rutka J, Rosenblum M, et al. Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sei USA. 1987; 84: 3526–3530.

    Google Scholar 

  28. Dewhurst S, Bresser J, Stevenson M, et al. Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV). FEBS Lett. 1987; 213: 138–143.

    PubMed  CAS  Google Scholar 

  29. Nelson J, Wiley C, Reynolds-Kohler C, et al. Human immunodeficiency virus detected in bowel epithelium from patients with gastro-intestinal symptoms. Lancet. 1988; 1: 259–262.

    PubMed  CAS  Google Scholar 

  30. Phillips D, Bourinbaiar A. Infection of CD4- negative epithelia in vitro (abstract 1094 ). Presented at Vlth International Conference on AIDS; San Francisco, CA; June 1990.

    Google Scholar 

  31. Maury W, Potts BJ, Rabson AB. HIV-1 infection of first-trimester and term human placental tissue: A possible mode of maternal- fetal transmission. J Infect Dis. 1989; 160: 583–588.

    PubMed  CAS  Google Scholar 

  32. Phillips DM, Tan X. HIV-1 infection of the trophoblast cell line BeWo: A study of virus uptake. AIDS Res Hum Retroviruses. 1992; 8: 1683–1691.

    PubMed  CAS  Google Scholar 

  33. Zachar V, Norskov-Lauritsen N, Juhl C, et al. Susceptibility of cultured human tropho- blasts to infection with human immunodeficiency virus type 1. J Gen Virol. 1991; 72: 1253–1260.

    PubMed  CAS  Google Scholar 

  34. Lewis SH, Reynolds-Kohler C, Fox HE, et al. HIV-1 in trophoblastic and villous Hofbauer cells, and hematologic precursors in eight- week fetuses. Lancet. 1990; 335 (l): 565–568.

    PubMed  CAS  Google Scholar 

  35. Mano H, Chermann JC. Replication of human immunodeficiency virus type 1 in primary cultured placental cells. Res Virol. 1991; 142: 95–104.

    PubMed  CAS  Google Scholar 

  36. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. 1993; 328: 327–335.

    PubMed  CAS  Google Scholar 

  37. Tindall B, Cooper DA. Primary HIV infection: Host responses and intervention strategies. AIDS. 1991; 5: 1–14.

    PubMed  CAS  Google Scholar 

  38. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991; 324: 961–964.

    PubMed  CAS  Google Scholar 

  39. Clark SJ, Saag MS, Decker WD, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med. 1991; 324: 954–960.

    PubMed  CAS  Google Scholar 

  40. Bolognesi DP. HIV antibodies and vaccine design. AIDS. 1989; 3 (suppl 1): S111–S118.

    PubMed  Google Scholar 

  41. Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 1987; 328: 345–348.

    PubMed  CAS  Google Scholar 

  42. Farizo KM, Buehler JW, Chamberland ME, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA. 1992; 267: 1798–1805.

    PubMed  CAS  Google Scholar 

  43. Macdonell KB, Chmiel JS, Poggensee L, et al. Predicting progression to AIDS: Combined usefulness of CD4 lymphocyte counts and p24 antigenemia. Am J Med. 1990; 89: 706–712.

    PubMed  CAS  Google Scholar 

  44. Fahey JL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serological markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990; 322: 166–172.

    PubMed  CAS  Google Scholar 

  45. Lifson AR, Hessol NA, Rutherford GW. Progression and clinical outcome of infection due to human immunodeficiency virus. Clin Infect Dis. 1992; 14: 966–972.

    PubMed  CAS  Google Scholar 

  46. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep. 1992; 41: 1–19.

    Google Scholar 

  47. Carpenter CCJ, Mayer KH, Stein MD, et al. Human immunodeficiency virus infection in North American women: Experience with 200 cases and a review of the literature. Medicine (Baltimore). 1991; 70: 307–325.

    CAS  Google Scholar 

  48. Jensen LP, O’Sullivan MJ, Gomez-Del-Rio M, et al. Acquired immunodeficiency (AIDS) in pregnancy. Am J Obstet Gynecol. 1984; 148: 1145–1146.

    PubMed  CAS  Google Scholar 

  49. Antoine C, Morris M, Douglas D. Maternal and fetal mortality in acquired immunodeficiency syndrome. NY State J Med. 1986; 86: 443–445.

    CAS  Google Scholar 

  50. Minkoff HL, De Ragl RH, Landesman S, et al. Pneumocystis carinii pneumonia associated with acquired immunodeficiency syndrome in pregnancy: A report of three maternal deaths. Obstet Gynecol. 1986; 67: 284–287.

    PubMed  CAS  Google Scholar 

  51. Weitli CV, Roldan EO, Fojaco RM. Listeriosis as a cause of maternal death: An obstetric complication of the acquired immunodeficiency syndrome (AIDS). Am J Obstet Gynecol. 1983; 147: 7–9.

    Google Scholar 

  52. Koonin LK, Ellerbrock TV, Atrash HK, et al. Pregnancy-associated deaths due to AIDS in the United States. JAMA. 1989; 261: 1306–1309.

    PubMed  CAS  Google Scholar 

  53. Joncas JM, Delage G, Chad Z, et al. Acquired (or congenital) immunodeficiency syndrome in infants born of Haitian mothers. N Engl J Med. 1983; 308: 842.

    PubMed  CAS  Google Scholar 

  54. LaPointe N, Michaud J, Pekovic D, et al. Transplacental transmission of HTLV-III virus. N Engl J Med. 1985; 312: 1325–1326.

    Google Scholar 

  55. Kell PD, Barton SE, Smith DE, et al. A maternal death caused by AIDS. Case report. Br J Obstet Gynaecol. 1991; 98: 725–727.

    PubMed  CAS  Google Scholar 

  56. Sridama V, Pacini F, Yang LS, et al. De-creased levels of helper T-cells—A possible cause of immunodeficiency in pregnancy. N Engl J Med. 1982; 307: 352–356.

    PubMed  CAS  Google Scholar 

  57. Castilla JA, Rueda R, Vargas ML, et al. Decreased levels of circulating CD4-I- T lymphocytes during normal human pregnancy. J Reprod Immunol. 1989; 15: 103–111.

    PubMed  CAS  Google Scholar 

  58. Weinberg ED. Pregnancy associated immune suppression: Risks and mechanisms. Microbiol Pathog. 1987; 3: 747–749.

    Google Scholar 

  59. Brabin B J. Epidemiology of infection in pregnancy. Rev Infect Dis. 1985; 7: 579–603.

    PubMed  CAS  Google Scholar 

  60. Weinberg ED. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis. 1984; 6: 814–831.

    PubMed  CAS  Google Scholar 

  61. Berrebi A, Chaibi, Kobuch We, et al. Influence of pregnancy on HIV disease (Abstract WB 2046 ). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991: 193.

    Google Scholar 

  62. Alger LS, Farley JJ, Robinson BA, et al. Interactions of human immunodeficiency virus infection and pregnancy. Obstet Gynecol. 1993; 82: 787–796.

    PubMed  CAS  Google Scholar 

  63. MacCallum LR, Cowan FM, Whitelaw J, et al. Disease progression following pregnancy in HIV seropositive women (Abstract MBP 3). Presented at Vth International Conference on AIDS; Montreal, Canada; 1989: 222.

    Google Scholar 

  64. Connor E, Bardeguez A, Apuzzio J. The intrapartum management of the HIV infected mother and her infant. Clin Perinatol. 1989; 16: 899–908.

    PubMed  CAS  Google Scholar 

  65. Johnstone FD, MacCallum L, Brettle RP, et al. Does infection with HIV affect the outcome of pregnancy? Br Med J. 1988; 296: 467.

    CAS  Google Scholar 

  66. Terragna A, Anselmo M, Camera M, et al. Influence of pregnancy on disease progression in 31 HIV infected patients. Presented at International Conference on the Implications of AIDS for Mothers and Children; Paris, France; 1989; E2: 117.

    Google Scholar 

  67. Mazzarello G, Canessa A, Melica F, et al. Influence of pregnancy of HIV disease progression (Abstract WC 3235). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991: 354.

    Google Scholar 

  68. Bledsoe K, Olopoenia L, Barnes S, et al. Effect of pregnancy on progression of HIV infection (Abstract THC 652). Presented at Vlth International Conference on AIDS; San Francisco, CA 1990: 288.

    Google Scholar 

  69. Selwyn PA, Schoenbaum EE, Davenny K, et al. Prospective study of human immunodeficiency virus infection and pregnancy out-comes in intravenous drug users. JAMA. 1989; 261: 1289–1294.

    PubMed  CAS  Google Scholar 

  70. Di Leonardo L, Truscia D, Giaquinto C, et al. A prospective study of HIV in pregnant women (Abstract MBP 14). Presented at Vth International Conference on AIDS; Montreal, Canada; 1989: 224.

    Google Scholar 

  71. LaPointe N, Boucher M, Samson J, et al. Significant markers in the modulation of immunity during pregnancy and post-partum in a paired HIV positive and HIV negative population (Abstract WB 2054 ). Presented at Vllth International conference on AIDS; Florence, Italy; 1991: 195.

    Google Scholar 

  72. Minkoff HL, Willoughby A, Mendez H, et al. Serious infections during pregnancy among women with advanced human immunodeficiency virus infection. Am J Obstet Gynecol. 1990; 162: 30–34.

    PubMed  CAS  Google Scholar 

  73. Biggar RJ, Pahwa S, Minkoff H, et al. Immunosuppression in pregnant women infected with human immunodeficiency virus. Am J Obstet Gynecol. 1989; 161: 1239–1244.

    PubMed  CAS  Google Scholar 

  74. Johnstone FD, Willox L, Brettle RP. Sur-vival time after AIDS in pregnancy. Br J Obstet Gynaecol. 1992; 99: 633–663.

    PubMed  CAS  Google Scholar 

  75. Sunderland A. Influence of HIV infection on reproductive decisions. Obstet Gynecol Clin North Am. 1990; 17: 585–594.

    PubMed  CAS  Google Scholar 

  76. Miotti PG, Dallabetta G, Ndovi E, et al. HIV-1 and pregnant women: Associated fac-tors, prevalence, estimate of incidence and role in fetal wastage in central Africa. AIDS. 1990; 4: 733–736.

    PubMed  CAS  Google Scholar 

  77. Mofenson LM, Stratton P, and Willoughby A. HIV in pregnancy and effects on the fetus and infant. In: Mishell DR, Kirschbaum TH, Morrow CP, eds. Yearbook of Obstetrics and Gynecology, 1992 ed. St. Louis, MO: Mosby Yearbook; 1992:xiii–xlii.

    Google Scholar 

  78. Minkoff H, Nanda D, Menez R, et al. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex. Obstet Gynecol. 1987; 69: 285–287.

    PubMed  CAS  Google Scholar 

  79. Gloeb DJ, O’Sullivan MJ, Efantis J. Human immunodeficiency virus infection in women. The effects of human immunodeficiency virus on pregnancy. Am J Obstet Gynecol. 1988: 159: 756–761.

    PubMed  CAS  Google Scholar 

  80. Minkoff HL, Henderson C, Mendez H, et al. Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol. 1990; 163: 1598–1604.

    CAS  Google Scholar 

  81. Hutto C, Parks WP, Lai S, et al. A hospital- based prospective study of perinatal infection with human immunodeficiency virus type 1. J Pediatr. 1991; 118: 347–353.

    PubMed  CAS  Google Scholar 

  82. Italian Multicentre Study. Epidemiology, clinical features and prognostic factors of pediatric HIV infection. Lancet. 1987; 2: 1043–1046.

    Google Scholar 

  83. Blanche S, Rouzioux C, Coscato MLG, et al. A prospective study of infants born to women seropositive for human immunodeficiency vius type 1. N Engl J Med. 1989; 320: 1643–1648.

    PubMed  CAS  Google Scholar 

  84. European Collaborative Study. Children born to women with HIV-1 infection. Natural history and risk of transmission. Lancet. 1991; 337: 253–260.

    Google Scholar 

  85. Gabiano C, Tovo PA, DeMartino M, et al. Mother to child transmission of human immunodeficiency virus type 1: Risk of infection and correlates of transmission. Pediatrics. 1992; 90: 369–374.

    PubMed  CAS  Google Scholar 

  86. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med. 1989; 320: 1643–1648.

    Google Scholar 

  87. Braddick MR, Kreiss JK, Embree JE, et al. Impact of maternal HIV infection on obstetrical and early neonatal outcome. AIDS. 1990; 4: 1001–1004.

    PubMed  CAS  Google Scholar 

  88. Temmerman M, Plummer FA, Mirza NB, et al. Infection with HIV as a risk factor for adverse obstetrical outcome. Department of Medical Microbiology, University of Nairobi, Kenya. AIDS. 1990; 4: 1087–1093.

    PubMed  CAS  Google Scholar 

  89. Hira SK, Kamanga J, Bhat GJ, et al. Perinatal transmission of HIV-1 in Zambia. Br Med J. 1989; 299: 1250–1252.

    CAS  Google Scholar 

  90. Halsey N, Boulos R, Holt E, et al. Transmis-sion of HIV-1 infections from mother to infants in Haiti. JAMA. 1990; 264: 2088–2092.

    PubMed  CAS  Google Scholar 

  91. Lepage P, Van dePerre P, Msellati P, et al. Natural history of HIV-1 infection in Rwanda: A prospective cohort study (Abstract W.C. 46). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  92. Bulterys M, Chao A, Kurawige JB, et al. Maternal HIV infection and intrauterine growth. A prospective cohort study in Butare, Rwanda (Abstract W.C. 3234 ). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  93. Oleske J, Minnefor A, Cooper R Jr, et al. Immune deficiency syndrome in children. JAMA. 1983; 249: 2345–2349.

    PubMed  CAS  Google Scholar 

  94. Scott GB, Fischl MA, Klimas N, et al. Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA. 1985; 253: 363–366.

    PubMed  CAS  Google Scholar 

  95. Jovaisis E, Koch MA, Schäfer A, et al. LAV/HTLV-III in a 20-week fetus. Lancet. 1985; 2: 1129.

    Google Scholar 

  96. Peutherer JF, Rebus S, Smith I, et al. Detection of HIV in the fetus: A study of six cases (Abstract 7235). Presented at IVth International Conference on AIDS; Stockholm, Sweden; 1988.

    Google Scholar 

  97. Sprecher S, Soumenkoff G, Puissant F, et al. Vertical transmission of HIV in a 15-week fetus. Lancet. 1986; 2: 288.

    PubMed  CAS  Google Scholar 

  98. Soeiro R, Rashbaum WK, Rubinstein A, et al. The incidence of human fetal HIV-1 infection as determined by the presence of HIV-1 DNA in abortus tissue. (Abstract W.C. 3250 ). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  99. Marion RW, Wiznia AA, Hutcheon RG, et al. Human T-cell lymphotropic virus type III (HTLV-III) embryopathy. A new dysmorphic syndrome associated with intrauterine HTLV-III infection. Am J Dis Child. 1986; 140: 638–640.

    PubMed  CAS  Google Scholar 

  100. Fermosel J, Gurbindo MD, Hernandeq Sampelayo T, et al. Dysmorphic features in children HIV positive (Abstract MP 167 ). Presented at Illrd International Conference on AIDS; Washington, DC; 1987.

    Google Scholar 

  101. Iosub S, Bamji M, Stone RK, et al. More on human immunodeficiency virus embryopathy. Pediatrics. 1987; 80: 512–516.

    PubMed  CAS  Google Scholar 

  102. Embree JE, Braddick M, Datta P, et al. Lack of correlation of maternal human immunodeficiency virus infection with neonatal malformations. Pediatr Infect Dis J. 1989; 8: 700–704.

    PubMed  CAS  Google Scholar 

  103. Carlin ME, Bauer M. Does the human immunodeficiency virus affect morphogenesis? Clin Res. 1988; 36: 58A.

    Google Scholar 

  104. Qazi QH, Sheikh TM, Fikrig S, et al. Lack of evidence for craniofacial dysmorphism in perinatal human immunodeficiency virus infection. J Pediatr. 1988; 112: 7–11.

    PubMed  CAS  Google Scholar 

  105. Mundy DC, Schinazi RF, Gerver AR, et al. Human immunodeficiency virus isolated from amniotic fluid. Lancet. 1987; 2: 459–460.

    PubMed  CAS  Google Scholar 

  106. DiMaria H, Corpotin C, Rouzious C, et al. Transplacental transmission of HTLV-III virus. Lancet. 1986; 2: 215–216.

    PubMed  Google Scholar 

  107. Rogers MF, Ou CY, Kilbourne B, et al. Advances and problems in the diagnosis of human immunodeficiency virus infection in infants. Pediatr Infect Dis J. 1991; 10: 523–531.

    PubMed  CAS  Google Scholar 

  108. Blanche S, Tardieu M, Duliege AM, et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection: Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child. 1990; 144: 1210–1215.

    PubMed  CAS  Google Scholar 

  109. Peuchmaur M, Delfaissy JF, Pons JC, et al. HIV proteins absent from placentas of 75 HIV-1 positive women studied by immunochemistry. AIDS. 1991; 5: 741–745.

    PubMed  CAS  Google Scholar 

  110. Jauniaux E, Nessmann C, Imbert C, et al. Morphological aspects of the placenta in HIV pregnancies. Placenta. 1988; 9: 633–642.

    PubMed  CAS  Google Scholar 

  111. Chandwani S, Greco MA, Mittal K, et al. Pathology and human immunodeficiency virus expression in placentas of seropositive women. Infect Dis. 1991; 163: 1134–1138.

    CAS  Google Scholar 

  112. Nelson AM, Firpo A, Kamenga M, et al. Pediatric AIDS and perinatal HIV infection in Zaire: Epidemiologic and pathologic findings. Prog AIDS Pathol. 1992; 3: 1–33.

    PubMed  CAS  Google Scholar 

  113. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. Br Med J. 1992; 304: 809–813.

    Google Scholar 

  114. Ongradi J, Ceccherini-Nelli L, Pistell M, et al. Acid sensitivity of cell-free and cell-associated HIV-1: Clinical implications. AIDS Res Hum Retroviruses. 1990; 6: 1433–1436.

    PubMed  CAS  Google Scholar 

  115. Wofsy CB, Cohen JB, Hauer LB, et al. Isolation of AIDS-associated retrovirus from vaginal and cervical secretions from women with antibody for the virus. Lancet 1986; 1: 527–529.

    PubMed  CAS  Google Scholar 

  116. Vogt MW, Witt DJ, Craven DE, et al. Isolation patterns of human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med. 1987; 106: 380–382.

    PubMed  CAS  Google Scholar 

  117. Pomerantz RJ,, de La Monte SM, Donegan SP et al. Human immunodeficiency virus infection of the uterine cervix. Ann Intern Med. 1988; 108: 321–327.

    PubMed  CAS  Google Scholar 

  118. Krieger JN, Coombs RW, Collier AC, et al. Fertility parameters in men infected with human immunodeficiency virus. J Infect Dis. 1991; 164: 386–388.

    Google Scholar 

  119. Henry K, Chinnock BJ, Quinn RP, et al. Concurrent zidovudine levels in semen and serum detected by radioimmunoassay in patients with AIDS or AIDS-related complex. JAMA. 1988; 259: 3023–3026.

    PubMed  CAS  Google Scholar 

  120. Hamed KA, Winters MA, Holodniy M, et al. Detection of human immunodeficiency virus type-1 in semen: Effects of disease stage and nucleoside therapy. J Infect Dis. 1993; 167: 798–802.

    PubMed  CAS  Google Scholar 

  121. LoCaputo S, Angarano G, Maggi P, et al. Effi-cacy of therapy with zidovudine in preventing heterosexual transmission of HIV. Presented at Und International Symposium on AIDS and Reproduction; Nice, France; 1993.

    Google Scholar 

  122. Liuzzi G, D’Abbraccio M, Nappa S, et al. Zidovudine (ZDV) in preventing the heterosexual transmission of HIV infection. Presented at Und International Symposium on AIDS and Reproduction; Nice, France; 1993.

    Google Scholar 

  123. Goedert JJ, Duliege AM, Amos CI, et al. High risk of HIV-1 infection for first-born twins. Lancet. 1991; 338 (2): 1471–1474.

    PubMed  CAS  Google Scholar 

  124. Ziegler JB, Johnson RO, Cooper DA, et al. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet. 1985; 1: 896–897.

    PubMed  CAS  Google Scholar 

  125. Palasanthiran P, Ziegler JB, Stewart GJ, et al. Breastfeeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis. 1993; 167: 441–444.

    PubMed  CAS  Google Scholar 

  126. Van de Perre P, Hitimana DG, Simonon A et al. Postnatal transmission of HIV-1 associated with breast abscess. Lancet. 1992; 339: 1490–1491.

    PubMed  Google Scholar 

  127. Datta P, Embree JE, Kreiss JK. Resumption of breast-feeding in later childhood: A risk factor for mother to child human immunodeficiency virus type 1 transmission. Pediatr Infect Dis J. 1992; 11: 974–975.

    PubMed  CAS  Google Scholar 

  128. Ryder RW, Manzila T, Baende E, et al. Evi-dence from Zaire that breast-feeding by HIV- 1 seropositive mothers is not a major route for perinatal HIV-1 transmission but does decrease morbidity. AIDS. 1991; 5: 709–714.

    PubMed  CAS  Google Scholar 

  129. De Martino M, Tovo PA, Tozzi AE, et al. HIV-1 transmission through breast-milk: Appraisal of risk according to duration of feeding. AIDS. 1992; 6: 991–997.

    PubMed  Google Scholar 

  130. Van de Perre P, Simonon A, Msellati P et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med. 1991; 325: 593–598.

    PubMed  Google Scholar 

  131. Centers for Disease Control. Recommenda-tions for assisting in the prevention of perinatal transmission of HTLV-II/LAV and AIDS. Morb Mortal Wkly Rep 1985;34:721–726, 731–732.

    Google Scholar 

  132. Sanchez E, Casabona J, Bosch A. HIV vertical transmission in Catalonia, Spain (Abstract M.C. 3021 ). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  133. Pratibha D, Embree J, Ndinya-Achola JO, et al. Perinatal HIV-1 transmission in Nairobi, Kenya: 5 year follow-up (Abstract M.C. 3 ). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  134. D’Arminio MA, Ravizza M, Muggiasca ML, et al. HIV-infected pregnant women: Possible predictors of vertical transmission (Abstract W.C. 49). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  135. Hague RA, Mok JYQ, MacCallum L, et al. Do maternal factors influence the risk of HIV? (Abstract W.C. 3237 ). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  136. Lallemant M, Lallemant LCS, Samba L, et al. Assessing the risk for mother-infant HIV- 1 transmission: A challenge in developing countries (Abstract M.C. 3078). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  137. Kreiss J, Datta P, Willerford D, et al. Vertical transmission of HIV in Nairobi: Correlation with maternal viral burden (Abstract M.C. 3062). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  138. Boue F, Pons JC, Ketros L, et al. Risk for HIV-1 perinatal transmission varies with the mother’s stage of HIV infection (Abstract Th.C. 44 ). Presented at Vlth International Conference on AIDS; San Francisco, CA; 1990.

    Google Scholar 

  139. St. Louis ME, Kabagabo U, Brown C, et al. Maternal factors associated with perinatal HIV transmission (Abstract M.C. 3027). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  140. Burns D, Muenz L, Walsh J, et al. Correlation of perinatal transmission of HIV-1 with mother’s lowest prepartum CD4 level (Ab-stract 463). Presented at 31st Interscience Conference on Antimicrobial Agents and Chemotherapy; Chicago, IL; 1991.

    Google Scholar 

  141. Tibaldi C, Palomba E, Ziarati N, et al. Maternal factors influencing vertical HIV trans¬mission (Abstract W.C. 3277). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  142. Rossi P, Moschese V, Broliden PA, et al. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gpl20 epitopes correlates with the noninfective status of children born to seropositive mothers. Proc Natl Acad Sei USA. 1989; 86: 8055–8058.

    CAS  Google Scholar 

  143. Broliden PA, Moschese V, Ljungren K, et al. Diagnostic implications of specific immunoglobulin G patterns born to HIV-infected women. AIDS. 1989; 3: 577–582.

    PubMed  CAS  Google Scholar 

  144. Rossi P, Moschese V. Mother-to-child trans-mission of human immunodeficiency virus. Fed Am Soc Exp Biol J. 1991; 5: 2419–2426.

    CAS  Google Scholar 

  145. Goedert JJ, Mendez H, Drummond JE, et al. Mother-to-infant transmission of human immunodeficiency virus type 1: Association with prematurity or low anti-gpl20. Lancet. 1989; 2: 1351–1354.

    PubMed  CAS  Google Scholar 

  146. Beyssen V, Meyohas MC, Gras G, et al. Neutralizing titers in sera from HIV-infected pregnant women and their correlation with maternal-fetal transmission (Abstract W.A. 1344 ). Presented at Vllth International Conference on AIDS; Florence, Italy; 1991.

    Google Scholar 

  147. Schaffer N, Parekh BS, Pau CP, et al. Maternal antibodies to V3 loop peptides of gpl20 are not associated with lack of HIV-1 perinatal transmission (Abstract W.C. 48). Presented at Vllth International AIDS Conference; Florence, Italy; 1991.

    Google Scholar 

  148. Allain JP, Matthew T, Coombs R, et al. Antibody to V3 loop does not predict vertical transmission of HIV (Abstract W.C. 2263 ). Presented at Vllth International AIDS Conference; Florence, Italy; 1991.

    Google Scholar 

  149. Wolinsky SM, Wike CM, Korber BTM, et al. Selective transmission of human immunodeficiency virus type-1: Variants from mothers to infants. Science. 1992;255:1134– 1137.

    PubMed  CAS  Google Scholar 

  150. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet. 1992; 339 (2): 1007–1012.

    Google Scholar 

  151. Pollack H, Borkowsky W, Krasinski K. Maternal syphilis is associated with enhanced perinatal HIV transmission. Presented at 30th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Atlanta, GA; October 21-24, 1990: 1274A.

    Google Scholar 

  152. Maiques V, Dela Torre R, Monieon J. Risk of prenatal infection by use of invasive fetal monitoring. Presented at IInd International Symposium on AIDS and Reproduction; Nice, France; 1993.

    Google Scholar 

  153. Konduri K, Jones T, Moore E, et al. Peripartum blood/secretion contact linked to vertical ransmission of HIV infection Am J Obstet Gynecol. 1993; 168: 420.

    Google Scholar 

  154. Sison AV, Campos JM. Laboratory methods for early detection of human immunodeficiency virus type 1 in newborns and infants. Clin Microbiol Rev. 1992; 5: 238–247.

    PubMed  CAS  Google Scholar 

  155. Centers for Disease Control. Interpretation and use of Western blot for serodiagnosis of human immunodeficiency virus type 1 infection. Morb Mortal Wkly Rep. 1989;38 (suppl):Sl-S7.

    Google Scholar 

  156. Comeau AM, Harris JA, Mcintosh K, et al. Polymerase chain reaction in detecting HIV among seropositive infants—Relation to clinical status at any age and to results of other assays. AIDS. 1992; 5: 271–278.

    CAS  Google Scholar 

  157. American College of Obstetricians and Gynecologists. Voluntary Testing for Human Immunodeficiency Virus. Committee Opinion No. 97. ACOG; 1991:1.

    Google Scholar 

  158. Stein MD, Rosene KA. Clues to enhancing the identification of human immunodeficiency virus-infected women. Obstet Gynecol. 1992; 80: 317–320.

    PubMed  CAS  Google Scholar 

  159. Institute of Medicine. Prenatal Screening for HIV infection. In: Hardy LM, ed. HIV Screening of Pregnant Women and Newborns. Washington, DC: National Academy Press; 1991: 33.

    Google Scholar 

  160. Holman S, Sunderland A, Berthaud M, et al. Prenatal HIV counseling and testing. Clin Obstet Gynecol. 1989; 32: 445–455.

    PubMed  CAS  Google Scholar 

  161. Working Group on HIV Testing of Pregnant Women and Newborns. HIV infection, pregnant women, and newborns: A policy proposal for information and testing. JAMA. 1990; 264: 2416–2420.

    Google Scholar 

  162. State-of-the-art conference on azidothymidine therapy for early HIV infection. Am J Med. 1990; 89: 335–344.

    Google Scholar 

  163. Fischl MA Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS- related complex. A double-blind, placebo- controlled trial. N Engl J Med. 1987; 317: 185–191.

    PubMed  CAS  Google Scholar 

  164. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4- positive cells per cubic millimeter. N Engl J Med. 1990; 322: 941–949.

    PubMed  CAS  Google Scholar 

  165. Aboulker JR, Swart AM. Preliminary analysis of the Concorde trial. Lancet 1993; 341: 889–890.

    PubMed  CAS  Google Scholar 

  166. Sande MA, Carpenter CCJ, Cobbs CG, Holmes KK, Sanford JP. For the National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-infected Patients. Antiretroviral Therapy for Adult HIV-Infected Patients Recommendations from a State-of-the-Art Conference JAMA 1993; 270: 2483–2489.

    Google Scholar 

  167. Flexner C. New antiretroviral agents in clinical development. Curr Opin Infect Dis. 1992; 5: 798–805.

    Google Scholar 

  168. Sperling RS, Stratton P, members of the Obstetric-Gynecologic Working Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Treatment options for human immunodeficiency virus-infected pregnant women. Obstet Gynecol. 1992; 79: 443–448.

    PubMed  CAS  Google Scholar 

  169. Grossman JH, Nies BM, Lopez-Zeno J, et al. Management and therapy of human immunodeficiency virus-infected pregnancies in maternal-fetal medicine fellowship training programs. Obstet Gynecol. 1992; 80: 985–990.

    PubMed  Google Scholar 

  170. O’Sullivan MJ, Boyer PJ, Scott GB, et al. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants. Phase I Acquired Immunodeficiency Syndrome AIDS Clinical Trials Group Study (protocol 082). Am J Obstet Gynecol. 1993; 168: 1510–1515.

    PubMed  Google Scholar 

  171. Sperling RS, Stratton P, O’Sullivan MJ, et al. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N Engl J Med. 1992; 326: 857–861.

    PubMed  CAS  Google Scholar 

  172. Lagakos S, Fischl MA, Stein DS, et al. Effects of zidovudine therapy in minority and other subpopulations with early HIV infection. JAMA. 1991; 266: 2709–2712.

    PubMed  CAS  Google Scholar 

  173. Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. Morb Mortal Wkly Rep. 1992; 41: 1–10.

    Google Scholar 

  174. Masur H. Prevention and treatment of Pneumocystis pneumonia. N Engl J Med. 1992; 327: 1853–1860.

    PubMed  CAS  Google Scholar 

  175. Schneider MME, Hoepelman AIM, Karel J, et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus. N Engl J Med. 1992; 327: 1836–1841.

    PubMed  CAS  Google Scholar 

  176. Minkoff HL, Moreno JD. Drug prophylaxis for human immunodeficiency virus infected pregnant women: Ethical considerations. Am J Obstet Gynecol. 1990; 163: 1111–1114.

    CAS  Google Scholar 

  177. Stratton P. HIV in pregnancy. Cont Obstet Gynecol. In press.

    Google Scholar 

  178. Centers for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: Guidelines for anergy testing and management of anergic persons at risk of tuberculosis. Morb Mortal Wkly Rep. 1991; 40: 27.

    Google Scholar 

  179. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis-We can’t afford not to try it. N Engl J Med. 1993; 328: 576–578.

    PubMed  CAS  Google Scholar 

  180. Centers for Disease Control. Recommendations for prevention of HIV transmission in health care settings. Morb Mortal Wkly Rep. 1987; 36: 189–202.

    Google Scholar 

  181. Centers for Disease Control. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. Morb Mortal Wkly Rep. 1989; 38: 1–37.

    Google Scholar 

Download references

Authors
  1. Pamela Stratton
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Wayne State University School of Medicine, 6071 West Outer Drive, 48235, Detroit, MI, USA

    Bernard Gonik M.D. (Professor and Vice Chairman Chief of Obstetrics and Gynecology—Grace Hospital) (Professor and Vice Chairman Chief of Obstetrics and Gynecology—Grace Hospital)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Stratton, P. (1994). Human Immunodeficiency Virus. In: Gonik, B. (eds) Viral Diseases in Pregnancy. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2640-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2640-6_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7620-3

  • Online ISBN: 978-1-4612-2640-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation